Navigation Links
Adaptis Named 'Top 100' Company for Fifth Consecutive Year
Date:7/1/2008

Annual Ranking Measures Healthcare Information Technology Revenue

SEATTLE, July 1 /PRNewswire/ -- Adaptis, a leading provider of business process outsourcing (BPO) solutions for health payers, today announced that the company has once again been named to the prestigious and highly anticipated Healthcare Informatics 15th annual Top 100 list. The compilation is published annually in the magazine's June 2008 issue.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050113/SFTH042LOGO)

"The Healthcare Informatics Top 100 is an esteemed listing of the best in the healthcare industry and we are very proud to be counted among this select group," Adaptis SVP and Chief Business Development Officer Jan Claesson said. "With our customer-focused service and technology offerings we are well- positioned to help health insurers make significant strides in their ongoing pursuit to effectively increase efficiency, improve accuracy and stay current with compliance while controlling escalating healthcare costs."

Perhaps most representative of the value Adaptis provides health insurers is its relationship with The Community Health Plan of Washington (CHPW) which includes more than 230,000 plan members and has quadrupled in size since Adaptis began work with the plan in 1997. In recent years Adaptis helped CHPW effectively launch its Medicare Advantage program. According to CHPW Chief Executive Officer Darnell Dent, "We knew it would be a push -- enrollment within six months of CMS approving our Medicare Advantage plan application; Adaptis teamed with us and we launched in record time. With Adaptis, partnership isn't just a word; it's a commitment."

To compile the rankings, Healthcare Informatics surveys a broad range of companies that provide products and services to the healthcare sector. Only health information technology (HIT) revenues are counted to determine wh
'/>"/>

SOURCE Adaptis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Adaptis Seminar to Provide Strategies for Managing Market Transformations
2. Adaptis Sponsors Two Upcoming Healthcare Conferences
3. Adaptis Launches New Website and URL Address
4. Adaptis Promotes Roya Rezai to Chief Compliance Officer
5. Adaptis Names Jan Claesson Senior Vice President and Chief Business Development Officer
6. Adaptis Compliance Officer Earns Advanced Certificate
7. Tela Sourcing, Inc., an Adaptis Company, Acquires HealthASPex Business
8. Three New Director-Level Appointments at Adaptis
9. Adaptis Supports Local Yakima-Based YWCA and National Diabetes
10. TMG Health President and CEO Jack Tighe Named Ernst & Young Entrepreneur Of The Year(R) 2008 in Philadelphia Region
11. Cadient Group President and CEO, Stephen Wray, Named 2008 Ernst & Young Entrepreneur Of The Year(R) in Greater Philadelphia Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... OH (PRWEB) December 20, 2014 ... contend they suffered uncontrollable bleeding and other serious ... Court, Eastern District of Louisiana for coordinated pretrial proceedings, ... on Multidistrict Litigation (JPML) issued an order Friday to ... actions pending in 22 federal courts to the Louisiana ...
(Date:12/19/2014)... It’s very easy to become overwhelmed with the holidays ... the wayside until Christmas and the New Year are over. ... that burning desire to just escape it all and get ... Telluride with a no-fuss, affordable package. Montrose Days Inn will ... and ensure that all accommodations are met. Plus, everyone has ...
(Date:12/19/2014)... Silver Dollar City is picking up ... the first time ever, Silver Dollar City has a title ... 2015, listing the park’s wood coaster Outlaw Run as the ... announced this week, Silver Dollar City is named in CNN ... USA Today’s 10Best awards for “Best Public Lights Display,” and ...
(Date:12/19/2014)... The Medspa at Hendrick in Abilene, ... respected cosmetic brand Juvéderm. Voluma XC treats volume loss ... Medspa at Hendrick is pleased to be able to ... to its clients. , Voluma is the first and ... treat the mid-face and cheek area. This non-invasive treatment ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- Potentially illness-causing E. coli ... at farmers markets, according to a new study. ... vendors from 13 farmers markets in Los Angeles and ... Out of almost 150 samples tested, 24 percent were ... salmonella, according to the researchers. Both types of ...
Breaking Medicine News(10 mins):Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 3Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 4Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Silver Dollar City Nets New Titles: Guinness Book of World Records, Plus CNN Travel, USA Today & Fodor’s Top Places for Christmas Lights 2Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:E. Coli Germs Found on Farmers Market Herbs 2
... 28, 2008) Scientists at NanoBio Corporation have demonstrated ... topical treatment for cold sores (herpes labialis), NB-001, speeds ... systemic drugs but without safety or toxicity concerns. , ... that a topical agent can attain equivalent efficacy rates ...
... WASHINGTON, Oct. 28 In recognition of,Veterans Day, ... with the Prostate Cancer Education Council, and the,American ... and,education event in the Redskins players, locker room ... to be proactive about their,health., The event ...
... Did you know that one in six men ... prostate cancer occurs,every 2.5 minutes and a man dies ... men,s health first., Listen to this report from ... access video, audio, text, graphics and,photos for free and ...
... propofol tied to cardiac arrest in patients with a ... Use of the sedative propofol is associated with a high ... seizures, according to a study by researchers at the Mayo ... with refractory status epilepticus (RSE) -- prolonged seizures that don,t ...
... common, potentially lethal disease, survey shows , , TUESDAY, Oct. 28 ... for developing diabetes, too few perceive the threat it can ... In fact, most respondents feared shark bites, plane crashes or ... diabetes, according to the pollsters. , "We undertook the survey ...
... PHILADELPHIA, Oct. 28 The Family Planning,Council was recently ... Human Services for a total of $3 million. These ... areas: the,use of Natural Family Planning as a method ... women; and, creating a model program to,provide family planning ...
Cached Medicine News:Health News:Topical treatment for cold sores achieves efficacy of oral drugs; represents paradigm shift 2Health News:Washington Redskins Open FedExField Locker Room to ALL Military Veterans for Free Health Screenings 2Health News:Sedative Could Be Deadly in People With Seizures 2Health News:Too Few Understand Diabetes' Dangers 2Health News:Too Few Understand Diabetes' Dangers 3Health News:Local Organization Receives Multi-Million Dollar Grants for Natural Family Planning, HIV Testing and Family Planning Services for Men 2
(Date:12/17/2014)... Tenn. , Dec. 17, 2014  Strategic Health ... management software solutions, today announced a strategic agreement with ... New Jersey regional marketplace.  This ... enhance the health and wellness solutions QualCare brings to ... and the surrounding region. QualCare plans ...
(Date:12/17/2014)... , December 17, 2014 ... nothing less than a hub of information concerning the biopharmaceutical ... A further addition to the recently launched institutional ... and has now been enriched by a new chapter in ... A richly detailed and panoramic hub on the ...
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 17, 2014 /PRNewswire/ ... Integrated Clinical Trial Services, LLC (ICTS), two firms ... trials announce that they have formed a joint ... i-CTMS will provide a broad range of patient ... medical device companies. i-CTMS will be ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... Dec. 10 Genomic Health, Inc. (Nasdaq: GHDX ) ... results from a study of Onco type DX(®) in ... the Southwest Oncology Group (SWOG), a National Cancer Institute-supported clinical ... published these results online as an "early release" to ...
... , SAN DIEGO, ... reported that positive data from a clinical trial evaluating the abuse ... 48th Annual Meeting of the American College of Neuropsychopharmacology. Data ... lorcaserin is very low. , "Human abuse liability studies of the ...
Cached Medicine Technology:Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4
Malis CMC-III Generator provides both coagulation and cutting outputs....
...
...
...
Medicine Products: